Hogan Lovells International LLP

This Practice Note deals with influencer marketing in Germany. It is aimed at social media talent (influencers) as well as at brand owners engaging in advertising. This Practice Note focuses on labelling and disclosure requirements, sanctions, and how disclosure is regulated. Subsistence of copyright in the sponsored content and key provisions in relevant agreements are also covered.

This Practice Note explores the changes introduced to the regulation of medicinal products in the EU by the Falsified Medicines Directive to combat the increase in the incidence of falsified medicinal products. First, the Practice Note considers what is meant by the term ‘falsified medicinal product’, before looking at the measures introduced by the Falsified Medicines Directive: greater control of active substances, obligations for actors in the supply chain, the introduction of safety features on the packaging of medicinal products and the common logo for websites selling medicinal products. This Practice Note also provides an overview of the UK regime for falsified medicines.

This Practice Note explains the regulatory frameworks which may apply to electronic cigarettes. It provides an introduction to the regime governing e-cigarettes as consumer products, and considers when e-cigarettes may be classified as medicinal products and/or medical devices.

This Practice Note provides an overview of the key aspects of Regulation (EU) 2024/2847, the EU Cyber Resilience Act (CRA), including its scope, key obligations for relevant economic operators, its sanctions regime and what the new requirements mean for organisations in practice.